期刊文献+

pcDNA3.1(+)/hTERT-tk真核表达质粒的构建及其在HepG-2细胞中的表达

Construction of pcDNA3.1(+)/hTERT-tk Eukaryotic Expression Plasmid and Its Expression in HepG-2 Cells
下载PDF
导出
摘要 目的:研究人端粒酶逆转录酶(hTERT)基因核心启动子调控的人单纯疱疹病毒胸苷激酶基因/更昔洛韦(HSV-tk/GCV)系统对肝癌HepG-2细胞的体外杀伤作用。方法:构建hTERT基因启动子调控的tk基因真核表达载体pcDNA3.1(+)/hTERT-tk,用脂质体法分别转染肝癌细胞(HepG-2)和正常肝细胞(L-02)后给予更昔洛韦(GCV),用TUNEL法观察自杀基因对肝癌细胞生长的影响。结果:HETRT启动子调控下的HSV-tk/GCV系统对肝癌HepG-2细胞有明显的杀伤作用,而对正常肝细胞则作用不明显。结论:hTERT-tk/GCV基因体系能够靶向杀伤肝癌细胞,有靶向治疗肝癌的潜力。 Objective:To observe the killing effect of HSV-tk/GCV system driven by human telomerase reverse transeriptase(hTERT)core promoter against human hepatocellular carcinoma cell line HepG-2 in vitro. Methods:pcDNA3.1 (+)/ hTERT-tk eukaryotic expression plasmid containing HSV-tk gene under the control of hTERT core promoter was constructed and was transfected into hepatoma cells (HepG-2)and normal hepatic cells (L-02)by liposome method. Then transfected cells were selected with G418, at last GCV was added and cell growth was observed by Tunnel. Results: HSV-tk/GCV system could significantly inhibited the growth of HepG-2 cell, and had little cytotoxieity to normal hepatic cell. Conclusion : HSV-tk/GCV system controlled by hTERT core promoter has selectively killing effect on HepG-2 cell in vitro.
出处 《山西中医学院学报》 2009年第1期56-57,60,共3页 Journal of Shanxi College of Traditional Chinese Medicine
关键词 靶向基因治疗 h-TERT启动子 自杀基因 target gene therapy h-TERT promoter suicide gene
  • 相关文献

参考文献8

  • 1De Giorgio M,Fagiuoli S.Management of hepatocellular carcinoma[J].Dig Dis,2007,25(3):279-281.
  • 2Yazawa K,FisherW E,Brunicardi F C.Current progress in suicide gene therapy for cancer[J].World J Surg,2002,26(7):783-789.
  • 3Hytiroglou P,Theise N D.Telomerase activation in human hepato-carcinogenesis[J].Am J Gastroen-terol,2006,101 (4):839-841.
  • 4Feldser D M,Greider C W.Short telomcres limit tumor progression in vivo by inducing senescence[J].Cancer Ce11,2007,11 (5):389-391.
  • 5Song J S.Adenovirus-mediated suicide SCLC gene therapy using increased activity of the hTERT promoter by the MMRE and SV40 enhancer[J].Biosci Biotechnol Biochem,2005,69(1):56-62.
  • 6Aramaki Y,Lee I,Arama H,et al.Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein reeeptor and expression under the control of the cyclin A promoter[J].Biol Pharm Bull,2003,26(3):357-360.
  • 7Sonabend A M,Ulasov I V,l.esniak M S,et al.Gene therapy trials for the treatment of high-grade gliomas[J].Gene Ther Mol Biol,2007,11 (A):79-92.
  • 8Iimuro Y,Fujimoto.Strategy of gene therapy for liver cirrohosis and hepatocellular carcinoma[J].J Hepatobiliary Panereat Surg,2003,10(1):45-47.Japanese females[J].Int J Med Sci,2007,4(3):146-152.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部